Skip to main content
. 2018 Jan 9;26(1):108–115. doi: 10.5606/tgkdc.dergisi.2018.14141

Table 4. Effects of clinical variables on survival rates.

  1-year survival 2-year survival 5-year survival
  Mean±SD Mean±SD Mean±SD
Age (year)      
<60  0.8±0.1 0.5±0.7 0.2±0.1
≥60 0.8±0.1 0.6±0.6 0.2±0.1
Histopathologic diagnosis      
Squamous cell carcinoma 0.8±0.1 0.7±0.1 0.2±0.1
Adenocarcinoma 0.9±0.1 0.7±0.1 0.4±0.1
Other  0.8±0.1 0.5±0.1 0.4±0.1
Stage      
IIB 0.9±0.0 0.7±0.1 0.3±0.1
IIIA 0.6±0.1 0.4±0.1 0.3±0.8
T3 criteria      
>7 cm 0.9±0.0 0.6±0.1 0.1±0.1
Chest wall invasion 0.9±0.1 0.6±0.1 0.5±0.1
Other invasions 0.6±0.1 0.5±0.1 0.4±0.1
Lymph node invasion      
N0 0.1±0.0 0.8±0.1 0.3±0.1
N1 0.6±0.1 0.5±0.1 0.5±0.1
N2 0.6±0.1 0.2±0.1 0.0±0.0
Type of operation      
Lobectomy 0.9±0.0 0.7±0.1 0.3±0.1
Pneumonectomy 0.7±0.1 0.4±0.1 0.1±0.1
Other  0.8±0.1 0.6±0.2 0.6±0.2
Chemotherapy      
Yes 0.9±0.0 0.7±0.1 0.2±0.1
No 0.5±0.1 0.3±0.1 0.3±0.1
Radiotherapy      
Yes 0.9±0.0 0.7±0.1 0.4±0.1
No 0.8±0.1 0.5±0.1 0.1±0.1
Recurrence      
Yes 0.8±0.1 0.3±0.1 0.0±0.0
No 0.8±0.1 0.7±0.1 0.3±0.1
SD: Standard deviation.